Locations:
Search IconSearch
May 25, 2022/Cancer/Research

Embracing the Emerging Role of “Expert” Patients in Cancer Care

How online education is redefining the patient-provider relationship

22-CNR-2877719-CQD-Hero-650×450-1

The plethora of information and educational resources available in online cancer communities has made it easier than ever for patients to develop an in-depth understanding of their disease. Armed with this knowledge, these “expert” patients – or “e-patients” – feel empowered to navigate their care and participate in shared decision-making with their providers. This evolving modern-day dynamic is transforming the traditional patient-provider relationship.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Because many patients have such a sophisticated understanding of their own specific disease, they stand in a much different (and better) place than those who expect physicians to be the sole experts,” says Cleveland Clinic medical oncologist Nathan Pennell, MD, PhD.

The rise of the e-patient

The term “e-patient” was first used in 1996 by researcher Tom Ferguson, MD, to describe “individuals who are equipped, enabled, empowered and engaged in their health and health care decisions.” Dr. Ferguson, who battled multiple myeloma and eventually succumbed to the disease, was the driving force behind the formation of the e-Patient Scholars Editorial Team. After his death in 2007, his colleagues published the white paper: “e-patients: how they can help us heal healthcare” to honor his longtime work.

In recent years, the role of e-patients has evolved from participation in online communities to engaging in different areas of research, advocacy and the formation of best practices.

Putting e-patients to work

In a recent article in JCO Oncology Practice, Dr. Pennell and his Taussig Cancer Institute collaborators reviewed the current literature to identify key areas where e-patients have already left their mark in cancer treatment. The article summarizes the emerging role of e-patients in three main categories – education and advocacy, research, and best practices – and describes opportunities for engaging this particularly motivated population.

The article also provides guidance for clinicians on how to best engage e-patients and tap into their expertise.

Advertisement

“Dealing with such a savvy, inquisitive group can be uncomfortable for physicians who are accustomed to being the sole authority. However, it’s important to remember that these experts often have a command of their disease that can strengthen the care partnership between patient and clinician,” Dr. Pennell says. “My advice to oncologists is to remain open minded, explore the patient’s expertise, offer resources, and connect newly diagnosed patients to the e-patients who may be able to help them on their journey.”

This open-minded approach also promotes shared decision-making between patients and their providers. In his own clinical practice, Dr. Pennell has treated rare forms of lung cancer in which patients’ expertise has proven especially beneficial.

“Physicians who remain receptive to the input of their most-knowledgeable patients can actually learn quite a lot,” he adds.

Recent years have also seen an increased interest in incorporating the patient voice in the drafting of national best practices guidelines and novel research directions.

“The passionate advocacy of e-patients has led to increased federal funding for a variety of cancer studies,” notes Dr. Pennell. “Their efforts have had an enormous influence on the direction and availability of national grants.”

Embracing the emerging role of e-patients

The rise of e-patients represents a unique opportunity for the cancer community to advance the field beyond improving clinical care. Dr. Pennell believes that the size and influence of the e-patient community will continue to grow as information about cancer becomes more readily available.

Advertisement

“E-patients are teaching the medical community how to better address the aspects of care that are most important to those battling cancer. By embracing the changing relationship we have with this burgeoning patient population, we can develop a partnership that respects and acknowledges the patient’s voice,” he concludes.

Advertisement

Related Articles

Physician checking patient's heart rate
July 15, 2026/Cancer

First-Generation BTK Inhibitors Associated with Higher Risk of Cardiac Events

Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.

Thyroid cancer illustration
July 13, 2026/Cancer/News & Insight

New ASCO Guidelines Help Clinicians Navigate Rapid Shifts in Thyroid Cancer Treatment

Expert recommendations introduce use of targeted agents

AML cells in blood flow
July 10, 2026/Cancer/Blood Cancers

Ziftomenib + Chemotherapy Drives Deep Remission in Frontline NPM1-m/KMT2A-r AML

Combination therapy may soon represent new standard of care

Researcher with microscope
June 26, 2026/Cancer

Testosterone May Offer Anti-Tumor Activity in Glioblastoma

Research findings offer clues for improving disease outcomes in men

Male patient with doctor
June 17, 2026/Cancer/Patient Support

Overcoming Taboos: Helping Men with Cancer Restore Sexual Health

Creating a safe space for patients

Masked patient with physician
June 15, 2026/Cancer/Patient Support

Managing Infection Risk in the Era of Cell Therapy

Long-term immune effects reshape preventative strategies and timelines

Immune checkpoint inhibitor illustration
June 12, 2026/Cancer/News & Insight

Immunotherapy Appears to Reduce the Risk of Secondary Primary Cancers

Large-scale database also reveals potential for immunotherapy to protect against cancer

T53 mutation illustration
June 10, 2026/Cancer/News & Insight

TP53 Mutation Acquisition Timing Influences Prognosis in Myeloproliferative Neoplasms

Findings may help guide discussions around prognosis and allogeneic stem cell transplantation

Ad